Clinical trial
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
NCT04735172 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 7, 2022
- Completion date
- August 31, 2029
- Enrollment
- 44 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease